Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3157355rdf:typepubmed:Citationlld:pubmed
pubmed-article:3157355lifeskim:mentionsumls-concept:C0403416lld:lifeskim
pubmed-article:3157355lifeskim:mentionsumls-concept:C0264939lld:lifeskim
pubmed-article:3157355pubmed:issue4lld:pubmed
pubmed-article:3157355pubmed:dateCreated1985-5-3lld:pubmed
pubmed-article:3157355pubmed:abstractTextTwo patients had phenylbutazone-induced systemic vasculitis syndrome. Both presented with acute oliguric renal failure, and renal biopsies showed severe crescentic glomerulonephritis with marked interstitial inflammatory cell infiltration. Withdrawal of phenylbutazone and treatment with immunosuppressives and plasma exchange led to recovery of renal function in one case.lld:pubmed
pubmed-article:3157355pubmed:languageenglld:pubmed
pubmed-article:3157355pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3157355pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3157355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3157355pubmed:statusMEDLINElld:pubmed
pubmed-article:3157355pubmed:monthAprlld:pubmed
pubmed-article:3157355pubmed:issn0003-9926lld:pubmed
pubmed-article:3157355pubmed:authorpubmed-author:JonesJ MJMlld:pubmed
pubmed-article:3157355pubmed:authorpubmed-author:DobbieJ WJWlld:pubmed
pubmed-article:3157355pubmed:authorpubmed-author:McLayAAlld:pubmed
pubmed-article:3157355pubmed:authorpubmed-author:LeungA CAClld:pubmed
pubmed-article:3157355pubmed:issnTypePrintlld:pubmed
pubmed-article:3157355pubmed:volume145lld:pubmed
pubmed-article:3157355pubmed:ownerNLMlld:pubmed
pubmed-article:3157355pubmed:authorsCompleteYlld:pubmed
pubmed-article:3157355pubmed:pagination685-7lld:pubmed
pubmed-article:3157355pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:meshHeadingpubmed-meshheading:3157355-...lld:pubmed
pubmed-article:3157355pubmed:year1985lld:pubmed
pubmed-article:3157355pubmed:articleTitlePhenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis.lld:pubmed
pubmed-article:3157355pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3157355pubmed:publicationTypeCase Reportslld:pubmed